相关实验视频

Updated: Jul 16, 2025

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy

Published on: January 31, 2025

瘤微环境中的脂质代谢重编程:从机制到治疗方法

Hao-Ran Jin^1,2, Jin Wang^1,2, Zi-Jing Wang^1,2

¹Department of Gastroenterology and Hepatology, West China Hospital, Sichuan University, No.37 Guoxue Road, Wuhou District, Chengdu, 610041, China.

Journal of hematology & oncology

|September 12, 2023

概括

癌细胞为生长和生存重新编程脂质代谢. 针对这些代谢途径和瘤微环境中的代谢途径,为癌症治疗提供了新的治疗策略.

科学领域:

在瘤学瘤学.
癌症新陈代谢癌症新陈代谢
脂质代谢脂质代谢是什么

背景情况:

脂质代谢重编程是癌症的一个关键特征,使瘤细胞能够维持增殖和在恶劣条件下生存.
瘤细胞改变脂质的获取和氧化,以促进它们的生长.
瘤微环境中的结构和免疫细胞也表现出代谢变化,影响瘤进展和免疫反应.

研究的目的:

阐明癌症中脂质代谢重编程的机制.
描述瘤微环境细胞中的脂质代谢及其对癌症的影响.
为了确定脂质代谢中的治疗点,并探索组合疗法.

主要方法:

关于癌症脂质代谢的当前文献的综述.
分析癌细胞,肌层细胞和免疫细胞中的代谢重编程.
针对脂质代谢的潜在治疗策略的识别和评估.

主要成果:

癌细胞广泛重编程脂质代谢,以支持不受控制的生长和生存.
瘤微环境的脂质代谢显著影响瘤表型和免疫逃避.
准脂质代谢为新型癌症疗法提供了一个有希望的途径.

结论:

了解脂质代谢重编程对于癌症治疗至关重要.
针对癌症和瘤微环境的脂质代谢提供了新的治疗机会.
涉及脂质代谢调节剂的组合疗法可能会增强抗瘤疗效.

关键词:

癌症的进展情况.免疫反应的免疫反应.脂质新陈代谢脂质新陈代谢有针对性的治疗.瘤微环境是一个微环境.

更多相关视频

Modeling Breast Cancer in Human Breast Tissue using a Microphysiological System

Modeling Breast Cancer in Human Breast Tissue using a Microphysiological System

Published on: April 23, 2021

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

相关概念视频

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...